| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJMOA003216 |
| P698 | PubMed publication ID | 11752354 |
| P50 | author | Ale Algra | Q58370115 |
| P2093 | author name string | Helmerhorst FM | |
| van der Graaf Y | |||
| Rosendaal FR | |||
| Cats VM | |||
| Tanis BC | |||
| van den Bosch MA | |||
| Kemmeren JM | |||
| P433 | issue | 25 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| P304 | page(s) | 1787-1793 | |
| P577 | publication date | 2001-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Oral contraceptives and the risk of myocardial infarction | |
| P478 | volume | 345 |
| Q56970511 | 2013 ESH/ESC Guidelines for the management of arterial hypertension |
| Q33744221 | 52-year-old woman with intractable nausea and vomiting |
| Q59621784 | Acute Myocardial Infarction During Pregnancy and the Puerperium in the United States |
| Q35577037 | Acute coronary syndrome in women of reproductive age |
| Q43626449 | Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. |
| Q39301728 | Application of electrospun fibers for female reproductive health |
| Q46834380 | Arterial thrombosis and drospirenone-containing pill (Yasmin). Is the pill to be absolutely avoided by women who smoke? |
| Q57004376 | Atherothrombosis and the pill: what ratio(nale) for the RATIO studies? |
| Q39424107 | Attitudes Toward Prohibiting Tobacco Sales in Pharmacy Stores Among U.S. Adults |
| Q88790034 | Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens |
| Q44481714 | Changes in prescription patterns of oral contraceptives in a northern Italian province: relation with venous thromboembolism |
| Q36106730 | Chemotherapy-induced ovarian failure: manifestations and management |
| Q37871833 | Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women |
| Q57275284 | Cigarette Smoking Women of Reproductive Age Who Use Oral Contraceptives: Results from the 2002 and 2004 Behavioral Risk Factor Surveillance Systems |
| Q26798531 | Combined hormonal contraceptive use among women with known dyslipidemias: a systematic review of critical safety outcomes |
| Q35565498 | Combined oral contraceptives and the risk of myocardial infarction. |
| Q36080057 | Combined oral contraceptives in the treatment of polycystic ovary syndrome |
| Q24187746 | Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke |
| Q36542363 | Contraception for the older woman: an update |
| Q37138852 | Contraceptive hormone use and cardiovascular disease |
| Q28219423 | Coronary artery disease in women: a review on prevention, pathophysiology, diagnosis, and treatment |
| Q45807181 | Determinants of oral contraception use in a southern European setting |
| Q40553746 | Drospirenone-containing combined oral contraceptives and the risk of arterial thrombosis: a population-based nested case-control study. |
| Q34636421 | Drospirenone-containing oral contraceptive pills and the risk of venous and arterial thrombosis: a systematic review. |
| Q24803759 | Dutch women with a low birth weight have an increased risk of myocardial infarction later in life: a case control study |
| Q38508952 | Dyslipidemia and cardiovascular disease in women |
| Q37012991 | Effect of Oral Contraceptive Pills on the Blood Serum Enzymes and DNA Damage in Lymphocytes Among Users |
| Q92964733 | Effect of six-month use of oral contraceptive pills on plasminogen activator inhibitor-1 & factor VIII among women with polycystic ovary syndrome: An observational pilot study |
| Q44182756 | Effects of low-dose OCs on weight in women with Central European nutritional habits and lifestyle |
| Q37874154 | Estrogen and thrombosis: controversies and common sense |
| Q37809855 | Estrogen-Free Oral Hormonal Contraception: Benefits of the Progestin-Only Pill |
| Q73690769 | Estrogens, platelets and lysosomes |
| Q35181580 | Estrogens, progestogens and thrombosis |
| Q33259834 | Estrogens, selective estrogen receptor modulators, and a selective estrogen receptor down-regulator inhibit endothelial production of tissue factor pathway inhibitor 1. |
| Q82455356 | Fatal Pulmonary Oedema Following Oxytocin Administration in a Pregnant Woman with Acute Myocardial Infarction |
| Q44724801 | Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C --> T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels |
| Q51947901 | Functional health and well-being of relatively young women with peripheral arterial disease is decreased but stable after diagnosis. |
| Q43207167 | High-calcium diet reduces blood pressure, blood volume and preserves vasorelaxation in oral contraceptive-treated female rats |
| Q43714467 | High-molecular-weight kininogen and the risk of a myocardial infarction and ischemic stroke in young women: the RATIO case-control study |
| Q35664040 | Higher risk of venous thrombosis associated with drospirenone-containing oral contraceptives: a population-based cohort study. |
| Q38250178 | Hormonal contraception, thrombosis and age. |
| Q38870757 | Hormonal contraception: venous and arterial disease |
| Q34143320 | How safe is emergency contraception? |
| Q40732678 | Hypercoagulability and the risk of myocardial infarction and ischemic stroke in young women. |
| Q64119237 | Hypercoagulability and the risk of recurrence in young women with myocardial infarction or ischaemic stroke: a cohort study |
| Q44618455 | Hyperhomocysteinemia and risk for peripheral arterial occlusive disease in young women |
| Q73355160 | Impact of hormonal deficit and cardiovascular risk factors on life expectancy in hypopituitarism |
| Q28742763 | In silico identification of drug targets for antifertility from natural products by differential reaction content analysis of metabolic pathways |
| Q43186682 | Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome |
| Q51039118 | Increased plasma viscosity in young women with polycystic ovary syndrome using an oral contraceptive containing 35 μg ethinyl estradiol and 2 mg cyproterone acetate. |
| Q35908838 | Infertility, fertility treatment, and risk of hypertension. |
| Q44253251 | Interventions for acute coronary syndrome in young women and oral contraceptives |
| Q37291898 | Is the difference in outcome between men and women treated by primary percutaneous coronary intervention age dependent? Gender difference in STEMI stratified on age. |
| Q22251459 | Ischemic heart disease in women: a focus on risk factors |
| Q93645918 | JournalScan |
| Q38202198 | Lipid pharmacotherapy for treatment of atherosclerosis. |
| Q36887503 | Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study |
| Q48006214 | Low-dose oral contraceptive-induced acute myocardial infarction |
| Q44488223 | Markers for cardiovascular disease in monozygotic twins discordant for the use of third-generation oral contraceptives |
| Q36631196 | Metabolic and clinical effects of progestogens |
| Q37864984 | Nicotine addiction causes unique detrimental effects on women's brains |
| Q28083349 | Novel contraceptive targets to inhibit ovulation: the prostaglandin E2 pathway |
| Q44213250 | Novel risk factors for peripheral arterial disease in young women. |
| Q37016804 | Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans |
| Q51535496 | Oral contraceptive use and increased plasma concentration of C-reactive protein. |
| Q33576311 | Oral contraceptives and myocardial infarction. |
| Q39130555 | Oral contraceptives use and the risk of myocardial infarction: a meta-analysis |
| Q74513898 | Pharmacoepidemiology and drug safety |
| Q38150419 | Pharmacokinetic evaluation of desogestrel as a female contraceptive |
| Q34774237 | Postmenopausal hormone replacement therapy and atherosclerosis. |
| Q40809455 | Pregnancy loss and risk of ischaemic stroke and myocardial infarction |
| Q33370819 | Procoagulant factors and the risk of myocardial infarction in young women |
| Q47741045 | Prothrombotic coagulation defects and cardiovascular risk factors in young women with acute myocardial infarction |
| Q37763371 | Risk factors for heart attack, stroke, and venous thrombosis associated with hormonal contraceptive use. |
| Q38110189 | Risk of cardiovascular events with hormonal contraception: insights from the Danish cohort study |
| Q47137256 | Risks, benefits size and clinical implications of combined oral contraceptive use in women with polycystic ovary syndrome |
| Q28222847 | Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration |
| Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
| Q30613038 | The drop that spilled the cup: acute myocardial infarction in a young woman with underlying thrombophilic polymorphisms and oral contraceptive use. |
| Q35134590 | The menopausal transition: characteristics and management |
| Q44111058 | The relation between Helicobacter pylori and atherosclerosis cannot be explained by a high homocysteine concentration. |
| Q36807472 | Therapy insight: guidelines for selection of contraception in women with rheumatic diseases |
| Q35145570 | Thrombophilias and gynaecology |
| Q46892234 | Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response |
| Q46921099 | Use of oral contraceptives and mortality during 14 years' follow-up of Norwegian women |
| Q37238147 | Venous thromboembolism in women |
| Q81317608 | [Update on contraception] |
Search more.